{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T05:22:57Z","timestamp":1791868977283,"version":"4.3.4"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2015,1,13]],"date-time":"2015-01-13T00:00:00Z","timestamp":1421107200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1007\/s00277-014-2298-3","type":"journal-article","created":{"date-parts":[[2015,1,12]],"date-time":"2015-01-12T00:06:30Z","timestamp":1421021190000},"page":"969-973","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":50,"title":["Antibiotic treatment as sole management of Helicobacter pylori-negative gastric MALT lymphoma: a single center experience with prolonged follow-up"],"prefix":"10.1007","volume":"94","author":[{"given":"Markus","family":"Raderer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"W\u00f6hrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Kiesewetter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Werner","family":"Dolak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heimo","family":"Lagler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Wotherspoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonhard","family":"Muellauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Chott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,1,13]]},"reference":[{"key":"2298_CR1","volume-title":"The World Health Organization classification of tumours of haematopoietic and lymphoid tissues","author":"SH Swerdlow","year":"2008","unstructured":"Swerdlow SH, Campo E, Harris NL et al (2008) The World Health Organization classification of tumours of haematopoietic and lymphoid tissues. WHO, Lyon"},{"key":"2298_CR2","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1136\/gut.2010.224949","volume":"60","author":"A Ruskone-Fourmestraux","year":"2011","unstructured":"Ruskone-Fourmestraux A, Fischbach W, Aleman BMP et al (2011) EGILS consensus report. Gastric extranodal marginal zone B-cell lymphoma of MALT. Gut 60:747\u2013758","journal-title":"Gut"},{"issue":"suppl 6","key":"2298_CR3","doi-asserted-by":"crossref","first-page":"v144","DOI":"10.1093\/annonc\/mdt343","volume":"24","author":"E Zucca","year":"2013","unstructured":"Zucca E, Copie-Bergman C, Ricardi U et al (2013) Gastric marginal zone lymphoma of MALT-type: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 24(suppl 6):v144\u2013v148","journal-title":"Ann Oncol"},{"key":"2298_CR4","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.cgh.2009.07.017","volume":"8","author":"A Zullo","year":"2010","unstructured":"Zullo A, Hassan C, Cristofari F et al (2010) Effects of Helicobacter pylori eradication on early stage gastric mucosa-associated lymphoid tissue lymphoma. Clin Gastroenterol Hepatol 8:105\u2013110","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2298_CR5","doi-asserted-by":"crossref","first-page":"88","DOI":"10.7326\/0003-4819-131-2-199907200-00003","volume":"131","author":"G Steinbach","year":"1999","unstructured":"Steinbach G, Ford R, Glober G et al (1999) Antibiotic treatment of gastric lymphoma of mucosa-associated lymphoid tissue. An uncontrolled trial. Ann Intern Med 131:88\u201395","journal-title":"Ann Intern Med"},{"key":"2298_CR6","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1136\/gut.48.3.297","volume":"48","author":"A Ruskone-Fourmestraux","year":"2001","unstructured":"Ruskone-Fourmestraux A, Lavergne A, Aegerter PH et al (2001) Predictive factors for regression of gastric MALT lymphoma after anti-Helicobacter pylori treatment. Gut 48:297\u2013303","journal-title":"Gut"},{"key":"2298_CR7","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1136\/gut.2005.083022","volume":"55","author":"M Raderer","year":"2006","unstructured":"Raderer M, Streubel B, Woehrer S et al (2006) Successful antibiotictreatment of Helicobacter pylori negative gastric mucosa associated lymphoid tissue lymphomas. Gut 55:616\u2013618","journal-title":"Gut"},{"key":"2298_CR8","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/j.1523-5378.2006.00382.x","volume":"11","author":"T Akamatsu","year":"2006","unstructured":"Akamatsu T, Mochizuki T, Okiyama Y et al (2006) Comparison of localized gastric mucosa-associated lymphoid tissue (MALT) lymphoma with and without Helicobacter pylori infection. Helicobacter 11:86\u201395","journal-title":"Helicobacter"},{"key":"2298_CR9","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s10120-006-0367-6","volume":"9","author":"K Nozaki","year":"2006","unstructured":"Nozaki K, Nomura S, Shimizu N et al (2006) Helicobacter pylori negative\/API2-MALT1 translocation-negative low-grade MALT lymphoma. Gastric Cancer 9:229\u2013234","journal-title":"Gastric Cancer"},{"key":"2298_CR10","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1007\/s12185-008-0187-z","volume":"88","author":"G Dong","year":"2008","unstructured":"Dong G, Liu C, Ye H et al (2008) BCL10 nuclear expression and t(11;18)(q21;q21) indicate nonresponsiveness to Helicobacter pylori eradication of Chinese primary gastric MALT lymphoma. Int J Hematol 88:516\u2013523","journal-title":"Int J Hematol"},{"key":"2298_CR11","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1620\/tjem.214.79","volume":"214","author":"S Terai","year":"2008","unstructured":"Terai S, Iijima K, Kato K et al (2008) Long-term outcomes of gastric mucosa-associated lymphoid tissue lymphomas after Helicobacter pylori eradication therapy. Tohoku J Exp Med 214:79\u201387","journal-title":"Tohoku J Exp Med"},{"key":"2298_CR12","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1572-0241.2007.01521.x","volume":"103","author":"T Nakamura","year":"2008","unstructured":"Nakamura T, Seto M, Tajika M et al (2008) Clinical features and prognosis of gastric MALT lymphoma with special reference to responsiveness to H. pylori eradication and API2-MALT1 status. Am J Gastroenterol 103:62\u201370","journal-title":"Am J Gastroenterol"},{"key":"2298_CR13","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1111\/j.1349-7006.2009.01139.x","volume":"100","author":"T Sumida","year":"2009","unstructured":"Sumida T, Kitadai Y, Hiyama T et al (2009) Antibodies to Helicobacter pylori and CagA protein are associated with the response to antibacterial therapy in patients with H. pylori positive API2-MALT1-negative gastric MALT lymphoma. Cancer Sci 100:1075\u20131081","journal-title":"Cancer Sci"},{"key":"2298_CR14","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.3748\/wjg.v16.i17.2158","volume":"16","author":"HS Park","year":"2010","unstructured":"Park HS, Kim YJ, Yang WI et al (2010) Treatment outcome of localized Helicobacter pylori-negative low-grade gastric MALT lymphoma. World J Gastroenterol 16:2158\u20132162","journal-title":"World J Gastroenterol"},{"key":"2298_CR15","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1136\/gutjnl-2011-300495","volume":"61","author":"S Nakamura","year":"2012","unstructured":"Nakamura S, Sugiyama T, Matsumoto T et al (2012) Long-term clinical outcome of gastric MALT lymphoma after eradication of Helicobacter pylori: a multicentre cohort follow-up study of 420 patients in Japan. Gut 61:507\u2013513","journal-title":"Gut"},{"key":"2298_CR16","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/hel.12033","volume":"18","author":"YJ Choi","year":"2013","unstructured":"Choi YJ, Kim N, Paik JH et al (2013) Characteristics of Helicobacter pylori-positive and Helicobacter-pylori negative gastric mucosa-associated lymphoid tissue lymphoma and their influence on clinical outcome. Helicobacter 18:197\u2013205","journal-title":"Helicobacter"},{"key":"2298_CR17","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1097\/MCG.0b013e318286ff72","volume":"47","author":"A Zullo","year":"2013","unstructured":"Zullo A, Hassan C, Ridolda L et al (2013) Eradication therapy in Helicobacter pylori-negative, gastric low-grade mucosa-associated lymphoid tissue lymphoma patients. A systematic review. J CLin Gastroenterol 47:824\u2013827","journal-title":"J CLin Gastroenterol"},{"issue":"1","key":"2298_CR18","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/bjh.12078","volume":"160","author":"C Copie-Bergman","year":"2013","unstructured":"Copie-Bergman C, Wotherspoon AC, Capella C et al (2013) GELA histological scoring system for post-treatment biopsies of patients with gastric MALT lymphoma is feasible and reliable in routine practice. Br J Haematol 160(1):47\u201352","journal-title":"Br J Haematol"},{"key":"2298_CR19","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/j.1523-5378.2006.00382.x","volume":"11","author":"T Akamatsu","year":"2006","unstructured":"Akamatsu T, Mochizuki T, Okiyama Y, Matsumoto A, Miyabayashi H, Ota H (2006) Comparison of localized gastric mucosa-associated lymphoid tissue (MALT) lymphoma with and without Helicobacter pylori infection. Helicobacter 11:86\u201395","journal-title":"Helicobacter"},{"key":"2298_CR20","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/MCG.0b013e31818ca609","volume":"43","author":"SJ Chung","year":"2009","unstructured":"Chung SJ, Kim JS, Kim H, Kim SG, Kim CW, Jung HC, Song IS (2009) Long-term clinical outcome of Helicobacter pylori-negative gastric mucosa-associated lymphoid tissue lymphoma is comparable to that of H. pylori-positive lymphoma. J Clin Gastroenterol 43:3","journal-title":"J Clin Gastroenterol"},{"issue":"5","key":"2298_CR21","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/S0016-5085(00)70167-3","volume":"118","author":"A Morgner","year":"2000","unstructured":"Morgner A, Lehn N, Andersen LP, Thiede C, Bennedsen M, Trebesius K, Neubauer B, Neubauer A, Stolte M, Bayerd\u00f6rffer E (2000) Helicobacter heilmannii-associated primary gastric low-grade MALT lymphoma: complete remission after curing the infection. Gastroenterology 118(5):821\u2013828","journal-title":"Gastroenterology"},{"issue":"2","key":"2298_CR22","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/j.1365-2141.2010.08179.x","volume":"150","author":"S Govi","year":"2010","unstructured":"Govi S, Dognini GP, Licata G et al (2010) Six-month oral clarithromycin regimen is safe and active in extranodal marginal zone B-cell lymphomas: final results of a single-centre phase II trial. Br J Haematol 150(2):226\u2013229","journal-title":"Br J Haematol"},{"issue":"8","key":"2298_CR23","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1182\/blood-2013-02-486522","volume":"122","author":"B Kiesewetter","year":"2013","unstructured":"Kiesewetter B, Raderer M (2013) Antibiotic therapy in nongastrointestinal MALT lymphoma: a review of the literature. Blood 122(8):1350\u20131357","journal-title":"Blood"},{"issue":"7","key":"2298_CR24","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1182\/blood-2002-10-3167","volume":"101","author":"H Ye","year":"2003","unstructured":"Ye H, Liu H, Raderer M et al (2003) High incidence of t(11;18)(q21;q21) in Helicobacter pylori-negative gastric MALT lymphoma. Blood 101(7):2547\u20132580","journal-title":"Blood"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-014-2298-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-014-2298-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-014-2298-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,6]],"date-time":"2024-06-06T13:47:26Z","timestamp":1717681646000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-014-2298-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1,13]]},"references-count":24,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["2298"],"URL":"https:\/\/doi.org\/10.1007\/s00277-014-2298-3","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,1,13]]}}}